Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists

医学 吸入器 哮喘 干粉吸入器 计量吸入器 家庭医学 内科学
作者
Iman A. Basheti,Helen K. Reddel,Carol Armour,Sinthia Bosnic‐Anticevich
出处
期刊:The Journal of Allergy and Clinical Immunology [Elsevier BV]
卷期号:119 (6): 1537-1538 被引量:196
标识
DOI:10.1016/j.jaci.2007.02.037
摘要

To the Editor: Correct inhaler technique is essential for effective drug delivery in asthma. High rates of incorrect technique (28% to 68%) with pressurized metered-dose inhalers and dry-powder inhalers have been reported,1Fink J.B. Rubin B.K. Problems with inhaler use: a call for improved clinician and patient education.Respir Care. 2005; 50: 1360-1374PubMed Google Scholar and poor technique with corticosteroid inhalers has been associated with poor asthma control and increased emergency department visits.2Giraud V. Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability.Eur Respir J. 2002; 19: 246-251Crossref PubMed Scopus (448) Google Scholar We have previously shown that a physical demonstration is a necessary component of device counselling to achieve optimal Turbuhaler (AstraZeneca, New South Wales, Australia) technique.3Basheti I.A. Reddel H.K. Armour C.L. Bosnic-Anticevich S.Z. Counseling about Turbuhaler technique: needs assessment and effective strategies for community pharmacists.Respir Care. 2005; 50: 617-623PubMed Google Scholar Pharmacists are in an excellent position to educate patients about inhaler technique because they are the last health care professionals seen by patients before an inhaled medication is used. In addition, international asthma guidelines recommend that pharmacists should form part of a team approach to patient education about the use of inhalers.4National Asthma Education and Prevention Program Expert Panel report 2. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda (MD)1997Google Scholar Hence the objective of this randomized controlled study was to investigate the effect on clinical and humanistic outcomes of a simple educational intervention concerning dry-powder inhaler technique delivered by community pharmacists to patients with asthma. The study was approved by the University of Sydney Human Ethics Committee and was completed before mandatory registration of clinical trials. A convenient sample of 120 registered community pharmacists in the Sydney metropolitan area was contacted by telephone. Thirty-one pharmacists were randomized (active, 16; control, 15), and 27 completed the study. Community pharmacists were trained to deliver education on Turbuhaler or Diskus (GlaxoSmithKline, Victoria, Australia) technique and peak flow meter (PFM) technique (active group) or PFM technique alone (control group). After training, all pharmacists demonstrated correct Turbuhaler and Diskus technique. Pharmacists then approached every second asthmatic patient who presented a Turbuhaler or Diskus prescription at their pharmacy. Inclusion criteria for patients were age of 14 years or older, English speaker, physician-diagnosed asthma, self-administration of inhaled corticosteroid through a Turbuhaler or Diskus with or without long-acting β2-agonist, and no change in asthma medication or dose for 1 month. After a 2-week run-in period during which PFM readings were recorded, patients in the active group visited the pharmacy for 5 visits (time = 0, 1, 2, 3, and 6 months) at which the intervention was delivered. The intervention included a specialized “show-and-tell” inhaler technique counselling service,3Basheti I.A. Reddel H.K. Armour C.L. Bosnic-Anticevich S.Z. Counseling about Turbuhaler technique: needs assessment and effective strategies for community pharmacists.Respir Care. 2005; 50: 617-623PubMed Google Scholar with augmented verbal counselling and physical demonstration with a placebo inhaler, addressing all steps in the inhaler technique checklist. Assessment and counselling were repeated up to 3 times if necessary, until the patient demonstrated the correct technique. At each subsequent visit, inhaler technique assessment and education were repeated. Patients in the control group visited the pharmacy for assessment at the same intervals and received standard care. Both groups also performed 2 weeks of peak flow monitoring before visits at 3 and 6 months. Data for humanistic outcomes were collected at 3 and 6 months for both the active and control groups. Turbuhaler and Diskus techniques were assessed by using published 9-point checklists specific for each device.5Van der Palen J. Klien J. Schildkamp A. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use.J Asthma. 1998; 35: 147-152Crossref PubMed Scopus (81) Google Scholar One hundred sixteen patients were enrolled, and 97 (84%) completed the study. At entry, correct inhaler technique was displayed by 7% of Turbuhaler users and 13% of Diskus users (Table I). Inhaler technique education took an average of 2.5 minutes per patient per visit. The intervention had a significant effect on inhaler technique and clinical and humanistic outcomes for both the Turbuhaler and Diskus groups. At 3 months, the correct technique was demonstrated by 85% of active Turbuhaler users and 96% of active Diskus users (control group not assessed). There was a significant difference in the proportion of Turbuhaler and Diskus users who were able to demonstrate correct technique after 6 months compared with the control group (Turbuhaler: 10/20 [50%] vs 2/14 [14%], P = .032; Diskus: 23/29 [79%] vs 3/21 [14%], P < .001, χ2 test). In the Turbuhaler active group there was a significantly greater proportion of patients demonstrating correct technique at each visit compared with baseline, with a slight trend toward a decrease between 3 and 6 months (P = .531, χ2 test). Results were similar for the Diskus group.Table IBaseline demographics and asthma management characteristics for asthmatic patientsDiskusTurbuhalerVariableActive (n = 30)Control (n = 24)Active (n = 23)Control (n = 20)Female sex (n [%])22 (73)14 (58)14 (61)9 (45)Age (y; mean [SD])51.4 (8.3)41.1 (20.0)45.48 (19.7)38.85 (18.4)Duration of preventer use (y [SD])1.7 (0.3)2.2 (1.9)2.6 (3.5)2.4 (2.9)Min%Max∗Min%Max (an index of peak expiratory flow variability) was calculated as the lowest morning peak expiratory flow over 2 weeks expressed as a percentage of the highest peak expiratory flow over the same 2-week period.6 (mean [SD])71.5 (9.7)76.0 (7.2)74.8 (9.2)71.2 (8.7)AQOL†AQOL7: range, 0 to 4 (best→worst). (mean [SD])1.6 (0.8)1.5 (0.7)1.5 (0.9)1.5 (0.5)PCAQ‡PCAQ (perceived control of asthma questionnaire)8: range, 0 to 55 (worst→best). (mean [SD])36.4 (6.4)39.6 (5.5)38.1 (5.6)38.1 (4.7)Patients with correct technique (n [%])3 (10)4 (17.4)2 (8.7)1 (5.3)∗ Min%Max (an index of peak expiratory flow variability) was calculated as the lowest morning peak expiratory flow over 2 weeks expressed as a percentage of the highest peak expiratory flow over the same 2-week period.6Reddel H.K. Salome C.M. Peat J.K. Woolcock A.J. Which index of peak expiratory flow is most useful in the management of stable asthma?.Am J Respir Crit Care Med. 1995; 151: 1320-1325Crossref PubMed Scopus (125) Google Scholar† AQOL7Marks G.B. Dunn S.M. Woolcock A.J. A scale for the measurement of quality of life in adults with asthma.J Clin Epidemiol. 1992; 45: 461-472Abstract Full Text PDF PubMed Scopus (347) Google Scholar: range, 0 to 4 (best→worst).‡ PCAQ (perceived control of asthma questionnaire)8Katz P.P. Yelin E.H. Eisner M.D. Blanc P.D. Perceived control of asthma and quality of life among adults with asthma.Ann Allergy Asthma Immunol. 2002; 89: 251-258Abstract Full Text PDF PubMed Scopus (88) Google Scholar: range, 0 to 55 (worst→best). Open table in a new tab Improvements in Turbuhaler and Diskus inhaler technique were reflected in improved clinical outcomes. Min%Max (index of peak expiratory flow variability)6Reddel H.K. Salome C.M. Peat J.K. Woolcock A.J. Which index of peak expiratory flow is most useful in the management of stable asthma?.Am J Respir Crit Care Med. 1995; 151: 1320-1325Crossref PubMed Scopus (125) Google Scholar at 3 months and 6 months adjusted for baseline was significantly higher (indicating less variability) for active compared with control patients (3 months: 83.8% ± 8.3% [mean ± SD] vs 77.6% ± 9.2%, P < .001; 6 months: 78.9% ± 9.7% vs 74.4% ± 8.9%, P = .002, 1-way analysis of covariance). When Turbuhaler and Diskus data were analysed separately, both groups showed a significant improvement in Min%Max (reduced variability) between the active and control groups at 3 months (Turbuhaler: 86.2% ± 7.0% vs 76.8% ± 9.8%, P = .005; Diskus: 82.1% ± 8.8% vs 78.5% ± 8.9%, P < .001), with a significant difference at 6 months only for Diskus (78.3% ± 7.9% vs 75.2% ± 8.8%, P = .005). For both inhaler groups combined, there were statistically significant and clinically important differences in asthma-related quality of life (AQOL)7Marks G.B. Dunn S.M. Woolcock A.J. A scale for the measurement of quality of life in adults with asthma.J Clin Epidemiol. 1992; 45: 461-472Abstract Full Text PDF PubMed Scopus (347) Google Scholar and perceived control (PC)8Katz P.P. Yelin E.H. Eisner M.D. Blanc P.D. Perceived control of asthma and quality of life among adults with asthma.Ann Allergy Asthma Immunol. 2002; 89: 251-258Abstract Full Text PDF PubMed Scopus (88) Google Scholar between the active and control groups at 3 months (AQOL: 0.8 ± 0.5 vs 1.35 ± 0.6; PC: 44.0 ± 5.7 vs 39.5 ± 4.4) and 6 months (AQOL: 0.8 ± 0.6 vs 1.3 ± 0.6; PC: 43.8 ± 4.9 vs 39.8 ± 4.0; P < .001 for each; 1-way analysis of covariance). Similar results were seen in the Turbuhaler and Diskus groups separately. In summary, this study demonstrated that a simple educational intervention taking only 2.5 minutes and targeting inhaler technique was feasible for delivery by community pharmacists and resulted in improved clinical and humanistic outcomes for patients with asthma. Active patients had significantly better inhaler technique, reduced peak expiratory flow variability, and improved AQOL and PC of asthma than control patients. For patients in the active group, inhaler technique, although maintained during monthly retraining, tended to decline over the final 3 months during which no further education was delivered. This was associated with a decrease in some asthma outcomes. These observations confirm that rechecking and re-educating patients about inhaler technique needs to be a regular and ongoing process. Community pharmacists are well placed to do this because they can engage the patient every time an inhaler is dispensed. This study thus highlights the critical role of face-to-face pharmacist-patient interactions about inhaled medications. Improved inhaler technique will have an effect on asthma control and health care use.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研团团完成签到,获得积分10
刚刚
简单的桃子完成签到,获得积分10
刚刚
yansie完成签到,获得积分10
1秒前
1秒前
舒适的石头完成签到,获得积分10
1秒前
1秒前
ppz完成签到,获得积分10
1秒前
wang完成签到,获得积分10
1秒前
谢志超发布了新的文献求助10
1秒前
2秒前
脑洞疼的应助被成长采纳,获得10
3秒前
迷人的芷波完成签到,获得积分10
3秒前
Adems完成签到 ,获得积分10
3秒前
凪启完成签到,获得积分10
4秒前
田様的应助被xx采纳,获得10
4秒前
搜集达人的应助被油炸萌萌猪采纳,获得10
4秒前
不呐呐完成签到,获得积分10
4秒前
adi12138发布了新的文献求助10
4秒前
ppz发布了新的文献求助10
4秒前
善良友安完成签到,获得积分10
4秒前
shen发布了新的文献求助10
4秒前
4秒前
churuoxi发布了新的文献求助10
5秒前
隋玉完成签到,获得积分10
5秒前
5秒前
树522发布了新的文献求助10
5秒前
张帆远航完成签到,获得积分10
5秒前
秋秋完成签到,获得积分10
6秒前
粗心的易云完成签到 ,获得积分10
6秒前
美好觅松的应助被卡密采纳,获得10
6秒前
wcw完成签到,获得积分10
6秒前
oddar完成签到 ,获得积分10
6秒前
6秒前
supman的应助被小刘爱科研采纳,获得50
6秒前
Ssssssinan的应助被坦率秀采纳,获得10
6秒前
oyc完成签到,获得积分10
7秒前
咎如天发布了新的文献求助10
7秒前
7秒前
willpower完成签到,获得积分10
7秒前
尹yin完成签到 ,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173962
求助须知:如何正确求助?哪些是违规求助? 9566073
关于积分的说明 21784460
捐赠科研通 7768184
什么是DOI,文献DOI怎么找? 3431663
关于科研通互助平台的介绍 2555907
邀请新用户注册赠送积分活动 2476936